In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

X4 Pharmaceuticals (XFOR) said it will conduct a one-for-thirty reverse stock split of the company’s common stock.

Company plans to set up offices in Greater China, the Americas, Asia-Pacific and Europe, brings in former executive to oversee some markets. Trade war may derail corporate earnings recovery in ...